Morning Market Losers
Regado Biosciences (NASDAQ: RGDO) shares dipped 52.82% to $1.34 after the company reported that it had permanently terminated the Regulate-PCI clinical trial.
Qihoo 360 Technology Co (NYSE: QIHU) shares declined 7.13% to $94.50 on Q2 results. Qihoo 360 reported Q2 adjusted EPADS of $0.50 on revenue of $317.90 million.
Neovasc (NASDAQ: NVCN) shares fell 6.77% to $5.09.
Evogene (NASDAQ: EVGN) slipped 6.42% to $13.12. Evogene shares have jumped 143.83% over the past 52 weeks, while the S&P 500 index has gained 20.02% in the same period.
Greif (NYSE: GEF) shares tumbled 5.96% to $47.30 after the company cut its FY14 earnings forecast.
Optibase (NASDAQ: OBAS) shares declined 5.16% to $5.88. On Friday, Optibase posted Q2 net income of $159,000, up from $619,000 in the year-ago period.
Leju Holdings (NYSE: LEJU) dropped 5.06% to $17.48.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.